SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Stock Picking - 2003

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: EVENT HORIZON III who wrote (116)1/12/2003 3:40:31 PM
From: scott_jiminez   of 383
 
<<Curious any biotechs come to mind that are advancing any autism products through R&D or Phase testing? Diagnostics in advance of expression?>>

Some questions:

1. Could you (or anyone else) provide a concise definition of Autism? Or is Autism a constellation of sociopathological behaviors (perhaps reflecting different biological/environmental roots) that have come to be grouped under a single rubric?

2. Your question about products appears to assume either some correlative factors have appeared with enough consistency or there is data on specific underlying organic anomalies to invite active pharmaceutical interest. Are there solid data to support these premises?

These are not rhetorical questions. I just don't know.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext